Key points are not available for this paper at this time.
Although point-of-care (POC) testing is widely considered a good idea, there is little agreement on what exactly it entails. While regulatory agencies such as the U.S. Food and Drug Administration (FDA) categorize tests based on criteria such as complexity and Clinical Laboratory Improvement Amendments (CLIA) waivers, the choice of criteria becomes vastly more complex when moving from issues concerning national to global health diagnostics.
Building similarity graph...
Analyzing shared references across papers
Loading...
Madhukar Pai
Nitika Pant Pai
Marzieh Ghiasi
Microbe Magazine
Building similarity graph...
Analyzing shared references across papers
Loading...
Pai et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69fc03921b97444a85df8542 — DOI: https://doi.org/10.1128/microbe.10.103.1
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: